Sign in

CIK 0001991792

  • Large accelerated filer

CG Oncology, Inc.

Sign in to watch
Ticker
CGON
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
371611499
Phone
+1 949-409-3700
Business address
3000 PEGASUS PARK DRIVE, SUITE 1640, DALLAS, TX, 75247
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Planned sale Director sold 1,964 shares at an average $63.50 ($124,714)
  6. 4 Exercise or conversion Chief Executive Officer acquired 64,612 shares (option exercise)
  7. 4 Exercise or conversion Chief Executive Officer acquired 102,871 shares (option exercise)
  8. 4 Planned sale Director sold 11,145 shares at an average $52.47 ($584,799)
  9. 4 Derivatives Options or other derivatives
  10. 3 Insider Initial Statement of Ownership
  11. 3 Insider Initial Statement of Ownership
  12. 4 Planned sale Director sold 1,000 shares at $41.43 ($41,430)
  13. 4 Planned sale Director sold 1,000 shares at $43.25 ($43,250)
  14. 4 Planned sale Director sold 5,903 shares at $43.99 ($259,673)
  15. 4 Planned sale Director sold 5,000 shares at $40.09 ($200,450)
  16. 4 Planned sale Director sold 12,755 shares at $39.19 ($499,868)
  17. 4 Planned sale Director sold 22,686 shares at an average $39.01 ($884,909)
  18. 4 Planned sale Director sold 1,000 shares at $35.10 ($35,100)
  19. 4 Open-market buy Director bought 1,515,151 shares at $33.00 ($49,999,983)
  20. 4 Planned sale Director sold 27,015 shares at an average $31.53 ($851,797)

Page 2 of 5 · 94 filings